Factors affecting survival in upfront metastatic breast carcinoma patients

dc.authorid0000-0002-6839-2632
dc.authorid0000-0002-8202-764X
dc.contributor.authorÜyeturk, Ümmügül
dc.contributor.authorBudakoğlu, Burçin
dc.contributor.authorTürker, İbrahim
dc.contributor.authorHelvacı, Kaan
dc.contributor.authorSönmez, Özlem Uysal
dc.date.accessioned2021-06-23T19:29:41Z
dc.date.available2021-06-23T19:29:41Z
dc.date.issued2012
dc.departmentBAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- JUN 01-06, 2012 -- Chicago, ILen_US
dc.description.abstractMetastatic breast cancer is a heterogenous disease. There are several subgroups according to pathological, biological and molecular behaviours of the tumor. Recurrent metastatic breast carcinoma (RMBC) and upfront metastatic breast carcinoma (UMBC) may differ according to clinical and prognostic characteristics. Intrinsic genetic heterogeneity may be responsible for these differences. To date, little is known about the clinical features and outcome of patients with UMBCen_US
dc.description.sponsorshipAmer Soc Clin Oncolen_US
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue15en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12491/7207
dc.identifier.urihttps://ascopubs.org/doi/abs/10.1200/jco.2012.30.15_suppl.e11540
dc.identifier.volume30en_US
dc.identifier.wosWOS:000318009800796en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.institutionauthorÜyeturk, Ümmügül
dc.language.isoenen_US
dc.publisherAmer Soc Clinical Oncologyen_US
dc.relation.ispartofJournal Of Clinical Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectMetastatic Breast Carcinoma Patientsen_US
dc.titleFactors affecting survival in upfront metastatic breast carcinoma patientsen_US
dc.typeConference Objecten_US

Dosyalar